TIMOTHY O'LEARY: Open Payments
NPI 1285657726 · GALLATIN, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,035 in 48 payments from 14 companies in 2025. Trend: 2023 $1,377 · 2024 $707 · 2025 $1,035
Food & beverage: $1,035
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $324 |
| PFIZER INC. | 7 | $152 |
| AstraZeneca Pharmaceuticals LP | 7 | $135 |
| ABBVIE INC. | 3 | $94 |
| Astellas Pharma US Inc | 3 | $58 |
| Lilly USA, LLC | 3 | $53 |
| TOLMAR, INC. | 2 | $41 |
| Corium, LLC | 1 | $34 |
| Exact Sciences Corporation | 2 | $33 |
| Corcept Therapeutics | 1 | $31 |
Products named: Ozempic, AIRSUPRA, Wegovy, ELIQUIS, Rybelsus, Veozah, NURTEC ODT, JATENZO.
Industry payments across TN — which companies pay providers there.
